70 Results
Sort By:
Published on April 30, 2018
NanoString Technologies said today it has expanded access to its developmental Digital Spatial Profiling (DSP) quantification technology through commercial partnerships with five contract research organizations. NanoString identified four of its five commercial CRO partners: Covance, Cancer Genetics Incorporated, Core Diagnostics, and Propath UK. The fifth CRO is undisclosed. DSP is…
Published on April 19, 2018
Metabolon said today it will perform large-scale metabolomic profiling on biological samples from U.S. veterans as part of the Million Veteran Program, through the company’s partnership with genomics services provider AKESOgen. The Million Veteran Program (MVP), a research effort launched by the U.S. Department of Veterans Affairs in 2011, is…
Published on November 16, 2017
Global Gene said it will partner with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) to study rare cancers in South Asian and Indian populations. Global Gene, a genomics data platform and applications developer, said it will offer…
Published on August 29, 2017
Next-generation sequencing studies by Alan E. Hoban, Ph.D., Gerard Clarke, Ph.D., and colleagues at the the APC Microbiome Institute at University College Cork have uncovered a link between the gut microbiome and microRNA (miRNA) expression in the brains of rats and mice that could feasibly lead to new approaches to…
Published on March 8, 2017
A collaborative study led by researchers at Nagoya University has developed a pioneering nanobiodevice that can separate microRNA (miRNA) from DNA/RNA mixtures obtained from cells in less than 100 ms. Previous research has shown that miRNA levels in bodily fluids strongly correlate with the presence and advance of various cancers—meaning…
Published on February 23, 2017
A team of scientists at the University of California (UC), Riverside has just published data that describes how they have targeted mosquito egg maturation at the molecular level, focusing on small regulatory RNA molecules, called microRNAs (miRNAs)—the targeting of these reproductive events could be an effective vector control strategy. The…
Published on January 20, 2017
Interpace Diagnostics said today that Best Med Opinion will be the exclusive provider of its molecular diagnostic tests for Israel, through a partnership that will promote Interpace’s tests to physicians and patients. The partnership covers Interpace’s three marketed tests: ThyGenX and ThyraMIR, both designed to determine the presence and absence…
Published on January 4, 2017
Interpace Diagnostics has joined the Blue Cross Blue Shield (BCBS) Association's Center for Clinical Effectiveness’ “Evidence Street” program, enabling the cancer-focused molecular diagnostics developer to present evidence designed to support future coverage decisions for its thyroid and pancreas diagnostic tests. Under an agreement announced Tuesday, Interpace said it will work…
Published on December 7, 2016
Nonprofit genomic analysis organization the Translational Genomics Research Institute (TGen) and California-based City of Hope have announced a collaboration to apply genomic research toward clinical practice through a partnership in which TGen will become a City of Hope subsidiary. The partnership aims to combine TGen’s expertise in genomic analysis and…